Melanoma Fundamentals

Melanoma: Definition and Epidemiology What Is Melanoma? Melanoma is a malignant tumor that arises from melanocytes, which are the pigment-producing cells in the skin. It is the most dangerous type of skin cancer because of its propensity to spread to other parts of the body (metastasize) and its relatively high mortality rate. Although melanoma most commonly occurs on the skin, it can rarely develop in other locations such as the mouth, intestines, the uvea of the eye (uveal melanoma), or the lungs (primary pulmonary melanoma). Who Develops Melanoma? Epidemiological Patterns Age Distribution The age at which melanoma develops is quite distinctive. About 80% of global melanoma cases occur in adults aged 50 years or older. The incidence rises sharply after age 50, peaking in the seventh and eighth decades of life. However, younger adults are not immune to this disease—it can develop at any age, and understanding age-related patterns is important for risk assessment. Sex Differences Men have a higher overall incidence of melanoma than women. Interestingly, this pattern reverses somewhat in younger populations: women under age 40 may have slightly higher rates than men of the same age group. This sex-specific difference likely reflects different patterns of sun exposure between men and women at different life stages. Race and Ethnicity Melanoma risk varies dramatically by ancestry and skin type. Populations with lighter skin phototypes—particularly those of Northern European descent—have the highest incidence rates. In contrast, melanoma is significantly less common in populations with darker skin, including those of African, Asian, and Latin American descent. A crucial point to understand: when melanoma does occur in individuals with darker skin, it often appears in unexpected locations. Rather than on sun-exposed areas of the body (like the face and arms, where it typically appears in lighter-skinned individuals), melanoma in darker-skinned populations frequently develops on non-sun-exposed sites such as the soles of the feet, palms of the hands, or under fingernails. This pattern suggests that different mechanisms may drive melanoma development in different populations. Geographic Variation Australia and New Zealand report the highest melanoma incidence rates globally. High rates also occur in Northern Europe and North America, particularly among populations of European descent. In contrast, Asia, Africa, and Latin America have substantially lower rates, again correlating with population skin type and ancestry patterns. Rising Incidence: The Melanoma Trend Melanoma incidence has been increasing since the 1960s in populations of primarily European descent. This upward trend reflects two main factors: increased ultraviolet (UV) radiation exposure and improved detection practices. Notably, the rise in incidence correlates with increased intermittent intense sun exposure and the rise in tanning-bed use, particularly among younger age groups. The good news is that mortality from melanoma has been decreasing in recent years, thanks to newer and more effective treatments that have become available. This improvement in outcomes, despite rising incidence, underscores the importance of both prevention and advances in melanoma management. Risk Factors: UV Radiation and Sun Exposure Environmental Risk Factors Ultraviolet (UV) radiation from sun exposure is the primary environmental risk factor for melanoma development. This relationship between UV exposure and melanoma risk is so well-established that it is considered one of the most important modifiable risk factors—meaning it's something individuals can actively control. The pattern of exposure matters: the rise in melanoma incidence correlates particularly with intermittent intense sun exposure (such as occasional sunbathing or beach vacations) rather than continuous occupational sun exposure. Additionally, tanning beds—which deliver concentrated UV radiation—markedly increase melanoma risk, and their avoidance is a key prevention strategy. Prevention Strategies Two evidence-based approaches reduce melanoma risk: Sunscreen use: Regular use of broad-spectrum sunscreen (which protects against both UVA and UVB radiation) reduces the risk of developing melanoma. Avoiding tanning beds: Avoidance of indoor tanning beds markedly lowers melanoma incidence. Genetic Risk Factors Several genes play crucial roles in melanoma development and risk. Understanding these genetic factors is important both for identifying high-risk families and for guiding treatment decisions. The CDKN2A Gene The CDKN2A gene encodes the p16 protein, which functions as a "brake" on cell division by inhibiting an enzyme called CDK4. Germline mutations (inherited mutations present in all cells) in CDKN2A markedly increase the risk for familial melanoma. Individuals who inherit these mutations have a substantially elevated lifetime risk of developing melanoma. The MC1R Gene The MC1R gene produces a receptor involved in determining skin pigmentation. Variants in this gene are associated with a higher risk of cutaneous melanoma independent of skin type and hair color. In other words, even people with the same skin tone may have different melanoma risks based on their MC1R variants. Somatic Mutations in Tumors While germline (inherited) mutations set baseline risk, somatic mutations (mutations that occur only within the tumor cells) drive melanoma progression and are critical for treatment planning: BRAF V600 mutations: These mutations drive uncontrolled cell proliferation and are present in a substantial proportion of melanomas. Because they are so common and actively drive cancer growth, BRAF mutations are important therapeutic targets. NRAS and KIT mutations: These occur in distinct melanoma subtypes and similarly influence treatment decisions. Hereditary Melanoma Syndrome Germline alterations in CDK4, CDKN2A, and MC1R together define hereditary atypical multiple-mole melanoma syndrome, a condition characterized by multiple atypical moles and markedly elevated melanoma risk. Pigmentation-Related Risk Factors Beyond genetic variants, certain pigmentation characteristics are strong risk factors for melanoma: Light skin color Freckling A high number of nevi (moles) These phenotypic features likely work together with genetic factors to determine overall melanoma risk. Summary: Key Epidemiological Takeaways The epidemiology of melanoma reveals a clear pattern: it primarily affects older adults of European descent living in regions with high UV exposure. However, genetics play a critical role—inherited mutations in genes like CDKN2A substantially elevate risk, and somatic mutations like BRAF V600 drive tumor progression. The rising incidence in recent decades reflects changing sun exposure behaviors, while decreasing mortality reflects improved treatments. Understanding both the environmental and genetic components of melanoma risk is essential for prevention strategies and for guiding individualized treatment approaches.